Cargando…

Association of serum 25-hydroxyvitamin D with metabolic syndrome and type 2 diabetes: a one sample Mendelian randomization study

BACKGROUND: Vitamin D deficiency has been associated with type 2 diabetes (T2D) and metabolic syndrome (MS) and its components. However, it is unclear whether a low concentration of vitamin D is the cause or consequence of these health conditions. Thus, this study aimed to evaluate the association o...

Descripción completa

Detalles Bibliográficos
Autores principales: Xiao, Jing, Lv, Jingyi, Wang, Shiyu, Zhou, Yang, Chen, Lunwen, Lu, Juying, Zhang, Xiaoyi, Wang, Xiaojian, Gu, Yunjuan, Lu, Qingyun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8244233/
https://www.ncbi.nlm.nih.gov/pubmed/34187381
http://dx.doi.org/10.1186/s12877-021-02307-6
_version_ 1783715891596230656
author Xiao, Jing
Lv, Jingyi
Wang, Shiyu
Zhou, Yang
Chen, Lunwen
Lu, Juying
Zhang, Xiaoyi
Wang, Xiaojian
Gu, Yunjuan
Lu, Qingyun
author_facet Xiao, Jing
Lv, Jingyi
Wang, Shiyu
Zhou, Yang
Chen, Lunwen
Lu, Juying
Zhang, Xiaoyi
Wang, Xiaojian
Gu, Yunjuan
Lu, Qingyun
author_sort Xiao, Jing
collection PubMed
description BACKGROUND: Vitamin D deficiency has been associated with type 2 diabetes (T2D) and metabolic syndrome (MS) and its components. However, it is unclear whether a low concentration of vitamin D is the cause or consequence of these health conditions. Thus, this study aimed to evaluate the association of vitamin D concentrations and its genetic risk scores (GRSs) with MS and its component diseases, such as T2D, in middle-aged and elderly participants from rural eastern China. METHODS: A subset of 2393 middle-aged and elderly individuals were selected from 70,458 participants of the Nantong Chronic Diseases Study of 2017–2018 in China. We used two 25-hydroxyvitamin D (25[OH]D) synthesis single-nucleotide polymorphisms (SNPs) (DHCR7-rs12785878 and CYP2R1-rs10741657) and two 25(OH) D metabolism SNPs (GC-rs2282679 and CYP24A1-rs6013897) for creating GRSs, which were used as instrumental variables to assess the effect of genetically lowered 25(OH) D concentrations on MS and T2D based on the Wald ratio. F statistics were used to validate that the four SNPs genetically determined 25(OH) D concentrations. RESULTS: Compared to vitamin D sufficient individuals, individuals with vitamin D insufficiency had an odds ratio (OR [95% confidence interval {CI}]) of MS of 1.30 (1.06–1.61) and of T2D of 1.32 (1.08–1.64), individuals with vitamin D deficiency had an ORs (95% CI) of MS of 1.50 (1.24–1.79) and of T2D of 1.47 (1.12–1.80), and those with vitamin D severe deficiency had an ORs (95% CI) of MS of 1.52 (1.29–1.85) and of T2D of 1.54 (1.27–1.85). Mendelian randomization analysis showed a 25-nmol/L decrease in genetically instrumented serum 25(OH) D concentrations using the two synthesis SNPs (DHCR7 and CYP2R1 genes) associated with the risk of T2D and abnormal diastolic blood pressure (DBP) with ORs of 1.10 (95%CI: 1.02–1.45) for T2D and 1.14 (95%CI: 1.03–1.43) for DBP. CONCLUSIONS: This one sample Mendelian randomization analysis shows genetic evidence for a causal role of lower 25(OH) D concentrations in promoting of T2D and abnormal DBP in middle-aged and elderly participants from rural China. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12877-021-02307-6.
format Online
Article
Text
id pubmed-8244233
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-82442332021-06-30 Association of serum 25-hydroxyvitamin D with metabolic syndrome and type 2 diabetes: a one sample Mendelian randomization study Xiao, Jing Lv, Jingyi Wang, Shiyu Zhou, Yang Chen, Lunwen Lu, Juying Zhang, Xiaoyi Wang, Xiaojian Gu, Yunjuan Lu, Qingyun BMC Geriatr Research BACKGROUND: Vitamin D deficiency has been associated with type 2 diabetes (T2D) and metabolic syndrome (MS) and its components. However, it is unclear whether a low concentration of vitamin D is the cause or consequence of these health conditions. Thus, this study aimed to evaluate the association of vitamin D concentrations and its genetic risk scores (GRSs) with MS and its component diseases, such as T2D, in middle-aged and elderly participants from rural eastern China. METHODS: A subset of 2393 middle-aged and elderly individuals were selected from 70,458 participants of the Nantong Chronic Diseases Study of 2017–2018 in China. We used two 25-hydroxyvitamin D (25[OH]D) synthesis single-nucleotide polymorphisms (SNPs) (DHCR7-rs12785878 and CYP2R1-rs10741657) and two 25(OH) D metabolism SNPs (GC-rs2282679 and CYP24A1-rs6013897) for creating GRSs, which were used as instrumental variables to assess the effect of genetically lowered 25(OH) D concentrations on MS and T2D based on the Wald ratio. F statistics were used to validate that the four SNPs genetically determined 25(OH) D concentrations. RESULTS: Compared to vitamin D sufficient individuals, individuals with vitamin D insufficiency had an odds ratio (OR [95% confidence interval {CI}]) of MS of 1.30 (1.06–1.61) and of T2D of 1.32 (1.08–1.64), individuals with vitamin D deficiency had an ORs (95% CI) of MS of 1.50 (1.24–1.79) and of T2D of 1.47 (1.12–1.80), and those with vitamin D severe deficiency had an ORs (95% CI) of MS of 1.52 (1.29–1.85) and of T2D of 1.54 (1.27–1.85). Mendelian randomization analysis showed a 25-nmol/L decrease in genetically instrumented serum 25(OH) D concentrations using the two synthesis SNPs (DHCR7 and CYP2R1 genes) associated with the risk of T2D and abnormal diastolic blood pressure (DBP) with ORs of 1.10 (95%CI: 1.02–1.45) for T2D and 1.14 (95%CI: 1.03–1.43) for DBP. CONCLUSIONS: This one sample Mendelian randomization analysis shows genetic evidence for a causal role of lower 25(OH) D concentrations in promoting of T2D and abnormal DBP in middle-aged and elderly participants from rural China. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12877-021-02307-6. BioMed Central 2021-06-29 /pmc/articles/PMC8244233/ /pubmed/34187381 http://dx.doi.org/10.1186/s12877-021-02307-6 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Xiao, Jing
Lv, Jingyi
Wang, Shiyu
Zhou, Yang
Chen, Lunwen
Lu, Juying
Zhang, Xiaoyi
Wang, Xiaojian
Gu, Yunjuan
Lu, Qingyun
Association of serum 25-hydroxyvitamin D with metabolic syndrome and type 2 diabetes: a one sample Mendelian randomization study
title Association of serum 25-hydroxyvitamin D with metabolic syndrome and type 2 diabetes: a one sample Mendelian randomization study
title_full Association of serum 25-hydroxyvitamin D with metabolic syndrome and type 2 diabetes: a one sample Mendelian randomization study
title_fullStr Association of serum 25-hydroxyvitamin D with metabolic syndrome and type 2 diabetes: a one sample Mendelian randomization study
title_full_unstemmed Association of serum 25-hydroxyvitamin D with metabolic syndrome and type 2 diabetes: a one sample Mendelian randomization study
title_short Association of serum 25-hydroxyvitamin D with metabolic syndrome and type 2 diabetes: a one sample Mendelian randomization study
title_sort association of serum 25-hydroxyvitamin d with metabolic syndrome and type 2 diabetes: a one sample mendelian randomization study
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8244233/
https://www.ncbi.nlm.nih.gov/pubmed/34187381
http://dx.doi.org/10.1186/s12877-021-02307-6
work_keys_str_mv AT xiaojing associationofserum25hydroxyvitamindwithmetabolicsyndromeandtype2diabetesaonesamplemendelianrandomizationstudy
AT lvjingyi associationofserum25hydroxyvitamindwithmetabolicsyndromeandtype2diabetesaonesamplemendelianrandomizationstudy
AT wangshiyu associationofserum25hydroxyvitamindwithmetabolicsyndromeandtype2diabetesaonesamplemendelianrandomizationstudy
AT zhouyang associationofserum25hydroxyvitamindwithmetabolicsyndromeandtype2diabetesaonesamplemendelianrandomizationstudy
AT chenlunwen associationofserum25hydroxyvitamindwithmetabolicsyndromeandtype2diabetesaonesamplemendelianrandomizationstudy
AT lujuying associationofserum25hydroxyvitamindwithmetabolicsyndromeandtype2diabetesaonesamplemendelianrandomizationstudy
AT zhangxiaoyi associationofserum25hydroxyvitamindwithmetabolicsyndromeandtype2diabetesaonesamplemendelianrandomizationstudy
AT wangxiaojian associationofserum25hydroxyvitamindwithmetabolicsyndromeandtype2diabetesaonesamplemendelianrandomizationstudy
AT guyunjuan associationofserum25hydroxyvitamindwithmetabolicsyndromeandtype2diabetesaonesamplemendelianrandomizationstudy
AT luqingyun associationofserum25hydroxyvitamindwithmetabolicsyndromeandtype2diabetesaonesamplemendelianrandomizationstudy